Senior Vice President and Chief Financial Officer
Mr. Chardonnet joined the Axcella team in 2019 and is providing oversight for the company’s finance, strategic planning, investor relations and capital management activities.
He joined Axcella following a 15-year tenure at Incyte Corporation during which he helped grow the company from a $500 million development-stage organization into a $20 billion commercial biopharmaceutical company. While at Incyte, Mr. Chardonnet served as Vice President, Treasurer and Principal Accounting Officer as well as the Head of Finance and Administration for the company’s European division. Most recently, as Incyte’s Vice President of Alliances, he aligned the company’s alliances with its overall strategy.
Prior to Incyte, Mr. Chardonnet served as Controller, Vice President of Finance and acting Chief Financial Officer of DrugAbuse Sciences, a privately held biotechnology company, and as a senior consultant at PricewaterhouseCoopers. He began his career working within the finance organizations at Guerbet Biomedical and Sanofi-Aventis.
Mr. Chardonnet received his Master of Business Administration from Vanderbilt University and his initial business degree from the Institut Superieur de Gestion in Paris.